Current Issue 2018  Archive 2017 
Biography
Biography

Editor-in-Chief of OBM Hepatology and Gastroenterology

Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.

Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.

Biography

The Associate Editor of OBM Hepatology and Gastroenterology

Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.

Special Issue

Peril and Promise: The Present and Future of Kidney Transplantation

Submission Deadline: November 30, 2018 (Open)               Submit Now

Guest Editor

Steven Potter, MD, FACS
Transplant Program Director, Chair of Division of Transplantation, East Texas Medical Center, 1100 E. Lake St., Ste. 340, Tyler, TX 75701, USA
E-Mail: [email protected]
Research Interests: renal transplantation; pancreas transplantation; living kidney donation; transplant immunosuppression; urology; urologic oncology

About This Topic

Renal transplantation is the gold standard therapy for treatment of end stage renal failure. However, the supply of living and deceased donor kidneys continues to be inadequate to meet demand. Long-term outcomes after renal transplantation improved dramatically for years, but have been relatively stable for the last decade. This special edition is open to submissions regarding existing and potential mechanisms to improve access to, and outcomes after, renal transplantation. Manuscripts are sought that address deceased donor kidney allocation, selection, and preservation, efforts to increase the utilization of high-risk organs, current and potential changes to the allocation system and regulatory environment, xenotransplantation, stem cell therapy, and novel immunosuppression approaches likely to impact outcomes and access to transplantation. We also seek manuscripts evaluating or proposing mechanisms to increase living donation via paired and chain donation, as well as ABO incompatible and crossmatch positive living donor transplants.

Planned Papers

Title: Tolerance in Kidney Transplantation
Authors: Yasir Qazi, Zaid Haddad, Irene Qazi

Publication

Case Report

Ectopic Pelvic Kidney with Anomalous Vascular Supply during Deceased Organ Procurement – Case Report

Ashley Rosenberg, Gilles Dongmo, Pallavi Yadav, Nathaniel Lee, Kunal Yadav
Received: August 13, 2018; Published: September 21, 2018; doi:10.21926/obm.transplant.1803020